central bank digital currency scheme Block

India's new central bank governor: we must be vigilant and flexible to the challenges we face.*ST Zhongli: The company's reorganization plan was approved by the court. *ST Zhongli announced that the company's reorganization plan had been approved by the Suzhou Intermediate People's Court and the reorganization procedure was terminated. The content of the reorganization plan is consistent with the previously disclosed draft, aiming at comprehensively solving the historical problems of the company's 1.805 billion yuan capital occupation and illegal guarantee. In the implementation stage of the reorganization plan, the company will be responsible for implementation and the manager will be responsible for supervision. If it is successfully implemented, it will help to optimize the company's asset-liability structure, enhance its sustainable operation and profitability, and have a significant impact on the relevant financial indicators in 2024.Light Media: "Nezha's Devil's Boy Makes a Sea" has rich derivatives planning. Light Media said on the interactive platform that at present, the company's IP derivative business is advancing normally. "Nezha's Devil Kids Roaring the Sea" has been planned and will launch derivative products with rich categories and wide price range in due course, including tide play, handcrafted products, statues, cards, stationery, food play, badges, billboards, publications, plush products and daily necessities, which can meet the diverse needs of different groups of people.

After the publication of CPI in the United States, the probability that the Fed will cut interest rates by 25 basis points in December has almost been fully priced. According to CME's "Fed Observation", the probability that the Fed will keep the current interest rate unchanged by December is 2.3%, and the cumulative probability of cutting interest rates by 25 basis points is 97.7%. The probability of keeping the current interest rate unchanged by January next year is 1.7%, the probability of cutting interest rates by 25 basis points is 71.2%, and the probability of cutting interest rates by 50 basis points is 27.1%.Broadcom US stocks rose 3.6% before the market, while Apple US stocks rose 0.3% before the market. In the news, Apple is cooperating with Broadcom around artificial intelligence (AI) chips.UN Secretary-General Guterres: I fully believe that the Syrian people can choose their own destiny.

ADB approved a loan of US$ 200 million for power infrastructure construction in Pakistan.MERO, the Czech pipeline operator: The oil transportation to the Czech Republic through the "Friendship" pipeline continues to run as planned.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)